ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.5407
-0.0078 (-1.42%)
At close: Jun 12, 2025, 4:00 PM
0.5500
+0.0093 (1.72%)
Pre-market: Jun 13, 2025, 8:17 AM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $28.90 million as of June 13, 2025. Its market cap has decreased by -95.79% in one year.
Market Cap
28.90M
Enterprise Value
-52.35M
1-Year Change
-95.79%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $28.90M, a decrease of -97.26%. That is a compound annual growth rate of -51.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 29.31M | -66.72% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |